Vertex Pharmaceuticals
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
VRTX News
Stock futures are inching lower, reflecting a shift toward more defensive posturing ahead of key inflation data and further signals from the Fed. Equity markets...
Vertex Pharmaceuticals (VRTX) announced that the FDA has granted breakthrough therapy designation to povetacicept for the treatment of IgAN. Pove is an investig...
Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of inaxaplin on kidne...
Analyst ratings
62%
of 34 ratingsMore VRTX News
Advertisement Most Popular Narrative: 20.9% Undervalued Vertex Pharmaceuticals (VRTX) has drawn investor attention lately, though not because of a headline-gr...
Analyst Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Vertex Pharmaceuticals and keeping the price target at $565.00. Elevate Your Inv...